Harvard Bioscience, Inc. (HBIO) Q3 EPS Drops to 5c; Revs Flat
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.67 +8.10%
Financial Fact:
Total operating expenses: 12.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating expenses: 12.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q3 EPS of $0.05, versus $0.08 reported last year. Revenue for the quarter came in at $26.38 million, versus $26.45 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Harvard Bioscience (HBIO) PT Raised to $7.50 at Benchmark on Q2 Beat and Raise
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
